SudaScan combats meth
This article was originally published in The Tan Sheet
Bartell Drugs launches a retail pilot program aiming to curtail purchases of pseudoephedrine products exceeding the 3.6 g monthly limit mandated by the federal Combat Meth Act. The program, launched in the Washington state-based drug store chain's Lynnwood, Wash., location, employs SudaScan, a patent-pending software and database program produced by technology firm Pharmitas that eliminates the need for paper-based logs. The handheld device "instantaneously reads and decodes two-dimensional driver's license barcodes and UPC product labels to enter the required information, reducing the logging time from more than three minutes to about 13 seconds," Bellevue, Wash.-based Pharmitas states. Following the 90-day pilot program, Bartell will make a decision on whether to implement the SudaScan system in its other stores. Pharmitas say it currently is in discussions with a number of pharmacy and retail chains about adopting SudaScan nationwide...
You may also be interested in...
Pharmitas' pilot program of the software and database system it developed to electronically scan and track sales of pseudoephedrine-containing drugs is nearing completion and is generating interest from retailers looking for an easier method of complying with log-book requirements mandated by the federal Combat Meth Act, the firm says
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.